Evidence map›Paper›PMID 33981689›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Biogenic Silver Nanoparticles as a Strategy in the Fight Against Multi-Resistant

María Belén Estevez, María Laura Casaux, Martín Fraga, Ricardo Faccio, Silvana Alborés

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Green Synthesis of Silver Nanoparticles fromMolecules (Basel, Switzerland) · 2025
    Article
  3. Review
  4. A Systemic Review on Fitness and Survival ofIndian journal of microbiology · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

María Belén EstevezÁrea de Microbiología, Departamento de Biociencias, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
María Laura CasauxPlataforma de Investigación en Salud Animal, Estación Experimental INIA La Estanzuela, Instituto Nacional de Investigación Agropecuaria, Colonia, Uruguay.
Martín FragaPlataforma de Investigación en Salud Animal, Estación Experimental INIA La Estanzuela, Instituto Nacional de Investigación Agropecuaria, Colonia, Uruguay.
Ricardo FaccioDepartamento de Experimentación y Teoría de la Estructura de la Materia y sus Aplicaciones (DETEMA), Facultad de Química, Centro NanoMat and Grupo Física, Universidad de la República, Montevideo, Uruguay.
Silvana AlborésÁrea de Microbiología, Departamento de Biociencias, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
Universidad de la República · UYInstituto Nacional de Investigación Agropecuaria · UY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious diseases are one of the most important health problems worldwide, one of the main causes being the development of multi-resistant microorganisms. Likewise, the zoonotic potential of some pathogens and their ability to transfer resistance mechanisms, reduce the therapeutic options in both humans and animals.

Indexed as

antimicrobialbiogenic nanoparticlesConfocal Raman Microscopymulti-resistanceSalmonella Typhimurium

Identifiers

PMID33981689
PMCPMC8107374
OpenAlexW3157810382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.